In another study, Zhang et al. tried to modify the surface of RBCm-PLGA NPs with the anti-EGFR-iRGD recombinant protein via a lipid insertion method to construct iE-RBCm-PLGA NPs and assess their active tumor-targeting ability in colorectal cancer models. The gene discussed is EGFR; the disease is neoplasm.